BioMarin Pharmaceutical Inc. (BMRN) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
105 DIGITAL DRIVE NOVATO, CA 94949 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,138 | 1,074 | 1,292 | 1,014 | 1,065 | 754 | |||
| Cash and cash equivalent | 943 | 755 | 725 | 587 | 649 | 437 | |||
| Short-term investments | 195 | 319 | 567 | 427 | 416 | 316 | |||
| Receivables | 661 | 634 | 461 | 373 | 448 | 377 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,233 | 1,107 | 894 | 777 | 699 | 680 | |||
| Inventory | 1,233 | 1,107 | 894 | 777 | 699 | 680 | |||
| Other current assets | 202 | 141 | 105 | 110 | 130 | 131 | |||
| Total current assets: | 3,232 | 2,956 | 2,751 | 2,274 | 2,342 | 1,942 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1,043 | 1,066 | 1,073 | 1,035 | 1,032 | 1,011 | |||
| Long-term investments and receivables | 521 | 611 | 334 | 508 | 285 | 412 | |||
| Long-term investments | 521 | 611 | 334 | 508 | 285 | 412 | |||
| Intangible assets, net (including goodwill) | 451 | 491 | 535 | 585 | 613 | 654 | |||
| Goodwill | 196 | 196 | 196 | 196 | 196 | 197 | |||
| Intangible assets, net (excluding goodwill) | 255 | 295 | 339 | 389 | 417 | 457 | |||
| Deferred income tax assets | 1,489 | 1,546 | 1,505 | 1,449 | 1,432 | 549 | |||
| Other noncurrent assets | 251 | 172 | 176 | 152 | 142 | 122 | |||
| Total noncurrent assets: | 3,757 | 3,886 | 3,624 | 3,729 | 3,506 | 2,748 | |||
| TOTAL ASSETS: | 6,989 | 6,842 | 6,375 | 6,003 | 5,848 | 4,690 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 607 | 683 | 573 | 492 | 493 | 571 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 2 | 10 | 8 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 204 | 165 | 192 | ||
| Accrued liabilities | 228 | 218 | 237 | 15 | 17 | 31 | |||
| Other undisclosed accounts payable and accrued liabilities | 379 | 465 | 336 | 270 | 301 | 339 | |||
| Debt | 494 | 362 | |||||||
| Business combination, contingent consideration, liability | 16 | 48 | |||||||
| Total current liabilities: | 607 | 1,177 | 589 | 540 | 493 | 933 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 595 | 593 | 1,083 | 1,079 | 1,075 | 486 | |||
| Long-term debt, excluding current maturities | 595 | 593 | 1,083 | 1,079 | 1,075 | 486 | |||
| Liabilities, other than long-term debt | 129 | 120 | 100 | 114 | 174 | 149 | |||
| Other liabilities | 129 | 120 | 100 | 99 | 114 | 98 | |||
| Business combination, contingent consideration, liability | 15 | 60 | 51 | ||||||
| Total noncurrent liabilities: | 724 | 713 | 1,183 | 1,193 | 1,249 | 635 | |||
| Total liabilities: | 1,331 | 1,890 | 1,772 | 1,733 | 1,742 | 1,568 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 5,658 | 4,952 | 4,603 | 4,271 | 4,106 | 3,122 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 5,802 | 5,612 | 5,405 | 5,192 | 4,993 | 4,833 | |||
| Accumulated other comprehensive income (loss) | 62 | (29) | (4) | 14 | (16) | 20 | |||
| Retained earnings (accumulated deficit) | (195) | (622) | (789) | (926) | (862) | (1,721) | |||
| Other undisclosed equity, attributable to parent | (11) | (10) | (9) | (10) | (10) | (10) | |||
| Total equity: | 5,658 | 4,952 | 4,603 | 4,271 | 4,106 | 3,122 | |||
| TOTAL LIABILITIES AND EQUITY: | 6,989 | 6,842 | 6,375 | 6,003 | 5,848 | 4,690 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,854 | 2,419 | 2,096 | 1,846 | 1,860 | 1,704 | ||
| Cost of revenue | (580) | (515) | (484) | (471) | (524) | (359) | ||
| Gross profit: | 2,274 | 1,904 | 1,612 | 1,376 | 1,336 | 1,345 | ||
| Operating expenses | (1,789) | (1,684) | (1,396) | (1,388) | (1,306) | (1,371) | ||
| Other undisclosed operating loss | (62) | (67) | (70) | (67) | (74) | |||
| Operating income (loss): | 484 | 158 | 150 | (82) | (37) | (100) | ||
| Nonoperating income | 75 | 58 | 18 | 10 | 9 | 22 | ||
| Investment income, nonoperating | 75 | 58 | 18 | 10 | 17 | 23 | ||
| Loss, foreign currency transaction, before tax | (8) | (1) | ||||||
| Interest and debt expense | (13) | (17) | (16) | (15) | (29) | (23) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 546 | 199 | 152 | (87) | (57) | (102) | ||
| Loss from equity method investments | (0) | (1) | ||||||
| Other undisclosed income (loss) from continuing operations before income taxes | (5) | (11) | (2) | 12 | 15 | 8 | ||
| Income (loss) from continuing operations before income taxes: | 542 | 189 | 150 | (75) | (42) | (95) | ||
| Income tax expense (benefit) | (115) | (21) | (8) | 11 | 901 | 71 | ||
| Income (loss) from continuing operations: | 427 | 168 | 142 | (64) | 859 | (24) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (64) | 859 | (24) | |
| Net income (loss) available to common stockholders, basic: | 427 | 168 | 142 | (64) | 859 | (24) | ||
| Interest on convertible debt | 7 | 8 | ||||||
| Net income (loss) available to common stockholders, diluted: | 434 | 168 | 142 | (64) | 867 | (24) | ||
Comprehensive Income ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 427 | 168 | 142 | (64) | 859 | (24) | ||
| Other comprehensive income (loss) | (18) | 31 | (36) | 15 | ||||
| Comprehensive income (loss): | 427 | 168 | 123 | (34) | 823 | (9) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 90 | (25) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | 517 | 143 | 123 | (34) | 823 | (9) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.